Dwoskin, L., Pivavarchyk, M., Joyce, B., Neugebauer, N., Zheng, G., Zhang, Z., … Crooks, P. Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 55, 31-63. https://doi.org/10.1007/978-0-387-78748-0_4 (Original work published 2009)

Dwoskin, L., Wooters, T., Sumithran, S., Siripurapu, K., Joyce, B., Lockman, P., … Bardo, M. (2008). N,N’-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics, 326(2), 563-76. https://doi.org/10.1124/jpet.108.136630

Dwoskin, L., Joyce, B., Zheng, G., Neugebauer, N., Manda, V., Lockman, P., … Crooks, P. (2007). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021 (Original work published 2007)